Purdue Pharma has won support from the attorneys general of 55 U.S. states and territories for its $7.4 billion settlement to ...

Purdue Pharma will pay more than $7 billion for the corporation's role in fueling the opioid epidemic that has killed hundreds of thousands of Americans. The Sackler family and Purdue Pharma ...

Shares in Hong Kong-based Regencell Bioscience Holdings nearly quadrupled in value amid a 38-to-1 stock split despite the ...

Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative Published. Jun 12, 2025 8:30am EDT. ... Type a symbol or company name.

Pharma Stock: A pharmaceuticals company on Tuesday, June 2, said its board will meet on June 13, 2025, to consider a bonus issue of equity shares and dividend payment for 2024-25.

Improved Pharma Expands Footprint at Kurz Purdue Technology Center, Now Occupying Over 5,500 Square Feet. By Improved Pharma; Jun 6, 2025 Jun 6, 2025 Updated 13 hrs ago; Facebook; ...

COLUMBIA, S.C. (WIS) - South Carolina Attorney General Alan Wilson announced a $7.8 billion settlement against Purdue Pharma and the Sackler family for their role in the nation’s opioid crisis.

NewAmsterdam shared new Phase 3 data showing obicetrapib reduced LDL-C by 33% and impacted Alzheimer's biomarkers ahead of July 2025 presentation.

Jazz Pharmaceuticals (JAZZ) stock gains as its lung cancer therapy Zepzelca, in combination with Roche's Tecentriq, receives FDA priority review. Read more here.

GREENVILLE, S.C. (FOX Carolina) - South Carolina Attorney General Alan Wilson announced a $7.4 billion settlement has been reached against the Sackler family and their company, Purdue Pharma, Inc.

NervGen Pharma targets a neglected market with significant unmet needs, offering high-risk, high-reward potential if NVG-291 succeeds in upcoming trials. Learn more on NGENF stock here.